NCT05586750View on ClinicalTrials.gov

Statins in Reducing Events in the Elderly Mind (STAREE-Mind) Imaging Substudy

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

341

Participants

Timeline

Start Date

September 19, 2019

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions
Dementia, MixedDementia, VascularDementia of Alzheimer TypeCognitive DeclineWhite Matter HyperintensityAgingNeuro-Degenerative Disease
Interventions
DRUG

Atorvastatin 40 Mg Oral Tablet

40 mg atorvastatin (2 x 20 mg atorvastatin daily), taken orally

DRUG

Placebo

2 x 20mg placebo (daily), taken orally. Identical appearance to study drug

Trial Locations (2)

3168

Monash Biomedical Imaging (MBI), Clayton

4029

Herston Imaging Research Facility (HIRF), Herston

All Listed Sponsors
collaborator

National Health and Medical Research Council, Australia

OTHER

lead

Monash University

OTHER